Interestingly, while large firms showed a trend of having a significantly lower success rate for entering clinical trials (0.29 times lower) compared to small to medium‐sized enterprises, this result was not statistically significant mainly due to its very small number of cases.
← all excerpts
From Lab to Clinic: Effect of Academia-Industry Collaboration Characteristics on Oncology Phase 1 Trial Entry.
1
—
—